Mária Ondrejcáková

Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder.

D. Jezova, M. Ondrejcáková, P. Wes, 2012, The international journal of neuropsychopharmacology.

Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis

D. Jezova, M. Eckertova, M. Ondrejcáková, 2011, British journal of pharmacology.

Effect of Hemidesmus indicus on ischemia–reperfusion injury in the isolated rat heart

M. Ondrejcáková, R. Balaraman, T. Ravingerová, 2010, Pharmaceutical biology.

Cell proliferation in the hippocampus and in the heart is modified by exposure to repeated stress and treatment with memantine.

D. Jezova, M. Ondrejcáková, J. Bakos, 2012, Journal of psychiatric research.

Neuroendocrine and cardiovascular parameters during simulation of stress-induced rise in circulating oxytocin in the rat

D. Jezova, R. Kvetňanský, M. Ondrejcáková, 2010, Stress.

Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins.

A. Lazou, M. Ondrejcáková, A. Adameová, 2009, Canadian journal of physiology and pharmacology.

Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia.

A. Breier, M. Ondrejcáková, T. Ravingerová, 2010, Canadian journal of physiology and pharmacology.

Prolonged oxytocin treatment in rats affects intracellular signaling and induces myocardial protection against infarction.

D. Jezova, M. Barančík, M. Ondrejcáková, 2012, General physiology and biophysics.